Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call Transcript

AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call Transcript

Aquestive Therapeutics Inc.
Aquestive Therapeutics, Inc. (AQST) Q1 2022 Results Conference Call May 04, 2022 08:00 AM ET Company Participants Bennett Watson - Investor Relations Keith Kendall - Chief Executive Officer Ernie Toth - Chief Financial Officer Daniel Barber - Chief Operating Officer Conference Call Participants Jason Butler - JMP Securities Thomas Flaten - Lake Street Andreas Argyrides - Wedbush Securities Raghuram Selvaraju - HC Wainwright Presentation Operator Good day and thank you for standing by. I would now like to introduce your host for today’s call, Bennett Watson. You may begin. Bennett Watson Thank you, operator. Good morning and welcome to today’s call. On today’s call, I’m joined by Keith Kendall, Chief Executive Officer and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance in the first quarter 2022, followed by a Q&A session. As a reminder, the Company’s remarks today correspond with

For further details see:

Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Aquestive Therapeutics Inc.
Stock Symbol: AQST
Market: NASDAQ
Website: aquestive.com
Menu
AQST AQST Quote AQST Short AQST News AQST Articles AQST Message Board
Get AQST Alerts

News, Short Squeeze, Breakout and More Instantly...